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Background:  It is well known that altered coagulation as well as fibrinogen genetic variability contribute to atherogenesis. In the present 
study we examined the combined effects of the rs1800790, rs2070011 fibrinogen polymorphisms on coagulation and endothelial function 
as well as the effect of coagulation on atherosclerotic manifestations.
methods:  We enrolled 422 patients with stable angina (SA) and 277 controls. The rs1800790 (G455A) and the rs2070011 (G58A) 
polymorphisms were estimated by appropriate genotyping. Fibrinogen and D-Dimer levels, as well as factors (f) V, X activity were 
measured by standard coagulometry techniques. Flow-mediated dilation (FMD) was assessed by brachial ultrasound.
results:  We have found the 455AA homozygosity was associated with raised fibrinogen levels in both groups (p=0.035 controls and 
p<0.001 SA). In addition, homozygotes for the 58A allele had lower fibrinogen levels in controls (p=0.038). Both the 58AA (p=0.027) and 
455AA homozygotes (p=0.022) had higher levels of D-Dimer in the SA group. The 455AA homozygotes had also increased fV activity in 
the SA group (p=0.048). No effects were observed on fX activity and FMD. Further analysis revealed that fibrinogen levels were strongly 
associated with SA (1.005 [1.003-1.007], p<0.001) as well as the presence of MI (1.003 [1.001-1.005], p=0.001). Similarly, D-Dimer levels 
were also strong predictors of CAD (1.001 [1.001-1.002], p<0.001), but not of MI (1.000 [1.001-1.001], p=0.083). Surprisingly, when fV and 
fX activities were examined for possible associations with clinical presentations, we found that fV activity was associated with increased 
number of diseased vessels (1.016 [1.001-1.030], p=0.037), while fX activity was strongly related to MI (0.985 [0.973-0.997], p=0.013).
Conclusion:  The rs1800790 variant increases significantly fibrinogen, D-Dimers levels and fV activity, contributing to atherogenesis. In 
addition, fibrinogen and D-Dimers levels are strong predictors of SA and MI. Interestingly, in our study we have shown for the first time to 
our knowledge that fV and fX are associated with the number of diseased vessels and the risk of MI respectively.
